First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis

Vanessa Espinosa1, Amariliz Rivera2

  • 1Center for Immunity and Inflammation, New Jersey Medical School, Rutgers-The State University of New JerseyNewark, NJ, USA; Graduate School of Biomedical Sciences, New Jersey Medical School, Rutgers-The State University of New JerseyNewark, NJ, USA.

Insights

Fungal infections are a growing threat, causing millions of deaths globally. Understanding innate immune cells

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Mycotic infections are increasingly prevalent and deadly, with rising mortality rates.
  • Immunosuppressive and myeloablative therapies contribute to higher incidences of fungal infections.
  • Invasive fungal infections cause approximately 1.5 million deaths annually, primarily from Cryptococcus, Candida, Aspergillus, and Pneumocystis.

Purpose of the Study:

  • To enhance understanding of host immune system mechanisms in containing fungal infections.
  • To facilitate the development of novel antifungal therapies.
  • To review host-fungi interactions, focusing on innate cell-mediated control of pulmonary aspergillosis.

Main Methods:

  • Review of current scientific literature on host-fungi interactions.
  • Focus on innate immune cell recognition and containment mechanisms.
  • Specific examination of pulmonary aspergillosis models.

Main Results:

  • Innate immune cells are critical for rapid recognition and containment of fungal pathogens.
  • Specific mechanisms of innate cell-mediated defense against fungi are elucidated.
  • Insights into host-pathogen interactions in pulmonary aspergillosis are provided.

Conclusions:

  • A deeper understanding of innate immunity is crucial for combating fungal infections.
  • Targeting innate immune responses may lead to effective new antifungal treatments.
  • Further research into host-fungi interactions, particularly in pulmonary aspergillosis, is warranted.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
17
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
86.0K